As on ymb
bobmenji1 • 3 hours ago
Birgit Anderegg to represent PRAN at World Orphan drug Congress Pitch and Partner
After noticing that Mr. Kempler was no longer showing up as a speaker on the World Orphan drug Congress website, I inquired and received a note saying: Mr Kempler is "unable to attend but Prana will still be present and represented by Birgit Anderegg." After googling her, I see that she is a Business Development professional with biotech firm experience. Unfortunately, I don't know (wasn't told) why Mr Kempler can not attend. I've sent another inquiry to try to find out and will post if I receive a response.
In any case, the agenda for the Pitch and Partner is out and it says the following: PBT2, a Phase II/III Huntington's drug candidate with benefits in cognition and function Less
Pitch and Partner
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 71906262 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 32338803 | 25 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |